Literature DB >> 26293926

Interplay between pathogenicity island carriage, resistance profile and plasmid acquisition in uropathogenic Escherichia coli.

Vera Calhau1,2, Sara Domingues1, Graça Ribeiro2, Nuno Mendonça1, Gabriela Jorge Da Silva1.   

Abstract

This study aimed to characterize the relationship between pathogenicity islands (PAIs), single virulence genes and resistance among uropathogenic Escherichia coli, evaluating the resistance plasmid carriage fitness cost related to PAIs. For 65 urinary E. coli, antimicrobial susceptibility and extended-spectrum β-lactamase production were determined with the Vitek 2 Advanced Expert system. Phylogroup determination, detection of PAIs and virulence genes papAH, papC, sfa/foc, afa/dra, iutA, kpsMII, cnf1, eaeA, hlyA, stx1 and stx2, plasmid replicon typing and screening for plasmidic resistance determinants qnr, aac(6')-Ib-cr, qepA and bla(CTX-M) were carried out by PCR. Conjugation was performed between a donor carrying IncF, IncK and bla(CTX-M-15), and receptors carrying one to six PAIs. The relative fitness of transconjugants was estimated by pairwise competition experiments. PAI IV(536) (68 %), gene iutA (57 %) and resistance to ampicillin were the most prevalent traits. PAI I(536), PAI II(536), PAI III(536) and PAI II(J96) were exclusively associated with susceptibility to amoxicillin/clavulanic acid, cefotaxime, ceftazidime, ciprofloxacin, gentamicin and trimethoprim/sulfamethoxazole, and were more prevalent in strains susceptible to ampicillin and cefalotin. PAI IV(536), PAI II(CFT073) and PAI I(CFT073) were more prevalent among isolates showing resistance to amoxicillin/clavulanic acid, cefalotin, cefotaxime, ceftazidime and gentamicin. An inverse relationship was observed between the number of plasmids and the number of PAIs carried. Transconjugants were obtained for receptors carrying three or fewer PAIs. The mean relative fitness rates of these transconjugants were 0.87 (two PAIs), 1.00 (one PAI) and 1.09 (three PAI). The interplay between resistance, PAI carriage and fitness cost of plasmid acquisition could be considered PAI specific, and not necessarily associated with the number of PAIs.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26293926     DOI: 10.1099/jmm.0.000104

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  5 in total

1.  Determining the Virulence Properties of Escherichia coli ST131 Containing Bacteriocin-Encoding Plasmids Using Short- and Long-Read Sequencing and Comparing Them with Those of Other E. coli Lineages.

Authors:  Ana Carolina da Cruz Campos; Francis M Cavallo; Nathália L Andrade; Jan Maarten van Dijl; Natacha Couto; Jan Zrimec; Jerome R Lo Ten Foe; Ana C P Rosa; Paulo V Damasco; Alex W Friedrich; Monika A Chlebowicz-Flissikowska; John W A Rossen
Journal:  Microorganisms       Date:  2019-11-06

2.  Differences of virulence factors, and antimicrobial susceptibility according to phylogenetic group in uropathogenic Escherichia coli strains isolated from Korean patients.

Authors:  Miri Hyun; Ji Yeon Lee; Hyun Ah Kim
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-11-10       Impact factor: 3.944

3.  Microarray Evaluation of Antimicrobial Resistance and Virulence of Escherichia coli Isolates from Portuguese Poultry.

Authors:  Nuno Mendonça; Rui Figueiredo; Catarina Mendes; Roderick M Card; Muna F Anjum; Gabriela Jorge da Silva
Journal:  Antibiotics (Basel)       Date:  2016-01-13

4.  Genetic diversity and antibiotic susceptibility of uropathogenic Escherichia coli isolates from kidney transplant recipients.

Authors:  Mohammad Mohammadzadeh; Mahnaz Tavakoli; Somayeh Yaslianifard; Ehsan Asadi; Reza Golmohammadi; Reza Mirnejad
Journal:  Infect Drug Resist       Date:  2019-07-09       Impact factor: 4.003

5.  Virulence factors and antimicrobial resistance of uropathogenic Escherichia coli (UPEC) isolated from urinary tract infections: a systematic review and meta-analysis.

Authors:  Gabriel Kambale Bunduki; Eva Heinz; Vincent Samuel Phiri; Patrick Noah; Nicholas Feasey; Janelisa Musaya
Journal:  BMC Infect Dis       Date:  2021-08-04       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.